Open access · CC-BY
via OpenAlex
Acarbose modulates microglial Pkm2 acetylation to reshape immunometabolism and preserve retinal neurons after ischemia-reperfusion
Yuwen Wen, Yanan Dou, Xiaohong Chen, Xiuxing Liu, Zhenlan Yang, Yingting Zhu, Zhidong Li, Caibin Deng, Ye Deng, Wenru Su, Yehong Zhuo
Journal of Neuroinflammation · 2026 · ▲ 4 citations
Deregulated nutrient-sensing
Mitochondrial dysfunction
Chronic inflammation
Partial reprogramming (OSK)
Mouse
Abstract
Retinal ischemia-reperfusion (IR) elicits microglia-driven neuroinflammation and mitochondrial failure that led to retinal ganglion cell (RGCs) loss, yet effective disease-modifying therapies remain limited. Acarbose (ACA), an α-glucosidase inhibitor widely used for diabetes, has recently been recognized for its dual regulatory potential on immune metabolism and aging-associated neurodegeneration. Here, we demonstrate that intravitreal ACA administration attenuates retinal inflammation and improves RGCs survival following IR injury. Single-cell RNA sequencing revealed extensive inflammatory activation and metabolic reprogramming across the retina, characterized by enhanced nicotinamide adenine dinucleotide (NAD) catabolism, particularly in microglia. ACA treatment was associated with reversal of these alterations, replenished NAD levels, and restored mitochondrial integrity. Integrative proteomic and biochemical analyses identified pyruvate kinase, muscle-type 2 (Pkm2) as a candidate regulatory node affected by ACA. Intravitreal delivery of siPkm2 partially protected against IR injury, and co-administration with ACA produced an additive trend in neuroprotection. Mechanistically, ACA upregulated sirtuin 1 (Sirt1) and reduced Pkm2 acetylation at lysine 270 (K270), which was linked to pro-inflammatory microglial activation. Structure-based virtual screening further identified HY-113082, a small molecule targeting Pkm2-K270, which synergized with ACA to suppress inflammation and enhance retinal protection. Moreover, Pkm2 fl/fl Cx3cr1-Cre mice conferred partial resistance to IR injury, but blunted the additional benefit of HY-113082 when combined with ACA, consistent with on-target engagement. Our findings support that ACA exerts retinal protection through the Sirt1-Pkm2-NAD axis, suggesting a metabolic checkpoint that integrates immune and mitochondrial regulation. This study provides mechanistic insight into ACA’s dual immunometabolic and neuroprotective actions, holding promise for therapeutic insights into neuroinflammation.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s12974-026-03838-8
- Canonical
- link ↗
- Fetched
- 2026-11-15 MST
Cite this
APA
Wen, Y., Dou, Y., Chen, X., Liu, X., Yang, Z., Zhu, Y., Li, Z., Deng, C., Deng, Y., Su, W., & Zhuo, Y. (2026). Acarbose modulates microglial Pkm2 acetylation to reshape immunometabolism and preserve retinal neurons after ischemia-reperfusion. <em>Journal of Neuroinflammation</em>. https://doi.org/10.1186/s12974-026-03838-8
Vancouver
Wen Y, Dou Y, Chen X, Liu X, Yang Z, Zhu Y, et al. Acarbose modulates microglial Pkm2 acetylation to reshape immunometabolism and preserve retinal neurons after ischemia-reperfusion. Journal of Neuroinflammation. 2026. doi:10.1186/s12974-026-03838-8.
BibTeX
@article{yuwen2026Acarbo,
title = {Acarbose modulates microglial Pkm2 acetylation to reshape immunometabolism and preserve retinal neurons after ischemia-reperfusion},
author = {Yuwen Wen and Yanan Dou and Xiaohong Chen and Xiuxing Liu and Zhenlan Yang and Yingting Zhu and Zhidong Li and Caibin Deng and Ye Deng and Wenru Su and Yehong Zhuo},
journal = {Journal of Neuroinflammation},
year = {2026},
doi = {10.1186/s12974-026-03838-8},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Neuroscience 2016
Open access · CC-BY
microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease
Molecular Neurobiology 2013
Open access · OA
α-Synuclein and Mitochondrial Dysfunction in Parkinson’s Disease
Nature Medicine 2017
Preprint · OA
α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies
Human Molecular Genetics 2013
Open access · OA
Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of -synuclein in Parkinson's disease models
Aging Cell 2022
Open access · CC-BY
Oral nicotinamide riboside raises NAD + and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin
Basic Research in Cardiology 2024
Open access · CC-BY